Recurrent anal cancer Clinical Trials
Conditions / Recurrent anal cancer
Delta Trials tracks 6 clinical trials for Recurrent anal cancer in its publicly accessible dataset. Among the listed trials, 1 open for participant enrollment and 4 trials have reached completion. This research is carried out at 14 clinical sites around the world. An additional 1 trial have active registrations outside the recruiting and completed categories. Since 2020, 1 trial have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
6
Total Trials
1
Recruiting
4
Completed
1
Other Active
1
Terminated since 2020
14
Study Locations
Browse by location (14 total)
- Chicago, United States 2 trialsAll trials in Chicago, United States
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States
- Columbus, United States 1 trialAll trials in Columbus, United States
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States
- The Bronx, United States 1 trialAll trials in The Bronx, United States
- Seattle, United States 1 trialAll trials in Seattle, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- Aarhus N, Denmark 1 trialAll trials in Aarhus N, Denmark
- Nashville, United States 1 trialAll trials in Nashville, United States
- La Jolla, United States 1 trialAll trials in La Jolla, United States
- Boston, United States 1 trialAll trials in Boston, United States
- Charlottesville, United States 1 trialAll trials in Charlottesville, United States
- Miami, United States 1 trialAll trials in Miami, United States
- Washington D.c, United States 1 trialAll trials in Washington D.c, United States
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States